
Loading, please wait...

Loading, please wait...

Researchers from BITS Pilani Hyderabad and Purdue University have created a revolutionary technology to advance portable liver diagnostics. Consequently, clinicians can now detect liver-related issues in under three minutes using a pocket-sized, handheld electrochemical sensor. Therefore, this innovation could dramatically improve healthcare access, especially in resource-limited rural clinics.
This novel point-of-care system utilizes a compact electrochemical sensor to measure bilirubin. Specifically, bilirubin serves as a crucial clinical marker for evaluating general liver function. Because elevated bilirubin levels often indicate serious conditions like jaundice or liver disease, rapid detection is extremely critical. Additionally, the device is roughly twice the size of a smartphone. In contrast to conventional testing that requires offline laboratory processing, this system delivers instant results using a tiny serum sample. Furthermore, the onboard system wirelessly transmits the readings directly to a smartphone.
To achieve high accuracy, the researchers coated the disposable sensor with gold nanoparticles. Moreover, they integrated a specialized nafion-chitosan membrane into the sensor architecture. Simultaneously, this layer actively attracts bilirubin while blocking interfering substances like proteins and uric acid. As a result, the sensor maintains high selectivity even at a physiological pH. Currently, the prototype has reached Technology Readiness Level 4, meaning laboratory validation is complete. However, clinical trials are still necessary before commercial release. Fortunately, the platform can easily adapt to identify other disease biomarkers in the future.
Q1: How long does it take for the new device to detect liver issues?
The pocket-sized device can analyze a small serum sample and provide accurate readings in under three minutes.
Q2: What biomarker does this portable liver diagnostics system measure?
The electrochemical sensor specifically measures bilirubin, which is a key biological marker used to evaluate liver function.
Q3: How does the device prevent interfering substances from corrupting the signal?
It utilizes a unique nafion-chitosan membrane that actively attracts bilirubin while blocking proteins, uric acid, and ascorbic acid.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers have developed a pocket-sized point-of-care device that accurately measures bilirubin levels to detect liver health issues in under three minute...
3 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today